Oncology Market

Oncology Market contains market size and forecasts of Oncology (Anti-cancer Drugs) in global, including the following market information:

• Global Oncology (Anti-cancer Drugs) Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Oncology (Anti-cancer Drugs) Market Sales, 2017-2022, 2023-2028, (K MT)
• Global top five Oncology (Anti-cancer Drugs) companies in 2021 (%)

The global Oncology (Anti-cancer Drugs) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Blood Cancer Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Oncology (Anti-cancer Drugs) include Roche, Novartis, Celgene, Amgen, Johnson & Johnson, GlaxoSmithKline, Eli lilly & Co, Pfizer and Merck & Co. and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Oncology (Anti-cancer Drugs) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Oncology (Anti-cancer Drugs) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global Oncology (Anti-cancer Drugs) Market Segment Percentages, by Type, 2021 (%)

• Blood Cancer
• Breast Cancer
• Gastrointestinal Cancer
• Prostate Cancer
• Others

Global Oncology (Anti-cancer Drugs) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global Oncology (Anti-cancer Drugs) Market Segment Percentages, by Application, 2021 (%)

• Chemotherapy
• Targeted Therapy
• Immunotherapy (Biologic Therapy)
• Hormonal Therapy
• Others

Global Oncology (Anti-cancer Drugs) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global Oncology (Anti-cancer Drugs) Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Oncology (Anti-cancer Drugs) revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Oncology (Anti-cancer Drugs) revenues share in global market, 2021 (%)
• Key companies Oncology (Anti-cancer Drugs) sales in global market, 2017-2022 (Estimated), (K MT)
• Key companies Oncology (Anti-cancer Drugs) sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Roche
• Novartis
• Celgene
• Amgen
• Johnson & Johnson
• GlaxoSmithKline
• Eli lilly & Co
• Pfizer
• Merck & Co.
• Sanofi